Skip to content
Catalyst

L-glutamineFinding

L-glutamine decreases tumour necrosis factor alpha concentration

lowersModerate evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“Compared with placebo, glutamine (MD −25.2; 95% CrI [−32.62, −17.95]) and probiotics (MD −12.55; 95% CrI [−15.19, −9.92]) significantly reduced TNF-α levels in CRC patients.”
Quoted verbatim from Comparative Effects of Different Nutritional Supplements on Inflammation, Nutritional Status, and Clinical Outcomes in Colorectal Cancer Patients: A Systematic Review and Network Meta-Analysis.
This finding among the 76 findings on its endpoint

L-glutamine

Tumour necrosis factor alpha concentration

lowers

Effect as reported

−25.2mean difference

CI −32.62 to −17.95

Who
colorectal cancer (CRC) patients; network meta-analysis estimate for glutamine versus placebo
Dose studied
not reported

Moderate evidencePMID 37375676 · 2023

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3P1J0GQ32VAN10DP25VHZHC